ATE265537T1 - Kinase für die stellen-spezifische phosphorylierung von i-kappa-b-alpha - Google Patents

Kinase für die stellen-spezifische phosphorylierung von i-kappa-b-alpha

Info

Publication number
ATE265537T1
ATE265537T1 AT97916786T AT97916786T ATE265537T1 AT E265537 T1 ATE265537 T1 AT E265537T1 AT 97916786 T AT97916786 T AT 97916786T AT 97916786 T AT97916786 T AT 97916786T AT E265537 T1 ATE265537 T1 AT E265537T1
Authority
AT
Austria
Prior art keywords
kinase
relates
site
antibodies
specific phosphorylation
Prior art date
Application number
AT97916786T
Other languages
English (en)
Inventor
Zhijian J Chen
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of ATE265537T1 publication Critical patent/ATE265537T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97916786T 1996-03-19 1997-03-19 Kinase für die stellen-spezifische phosphorylierung von i-kappa-b-alpha ATE265537T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61649996A 1996-03-19 1996-03-19
PCT/US1997/004195 WO1997035014A1 (en) 1996-03-19 1997-03-19 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a)

Publications (1)

Publication Number Publication Date
ATE265537T1 true ATE265537T1 (de) 2004-05-15

Family

ID=24469728

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916786T ATE265537T1 (de) 1996-03-19 1997-03-19 Kinase für die stellen-spezifische phosphorylierung von i-kappa-b-alpha

Country Status (11)

Country Link
US (4) US6107073A (de)
EP (1) EP0910645B1 (de)
JP (1) JP2000510328A (de)
KR (1) KR20000064670A (de)
AT (1) ATE265537T1 (de)
AU (1) AU728679C (de)
BR (1) BR9710408A (de)
CA (1) CA2249551A1 (de)
DE (1) DE69728880T2 (de)
ES (1) ES2217407T3 (de)
WO (1) WO1997035014A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972674A (en) 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
WO1998008955A1 (en) * 1996-08-26 1998-03-05 Signal Pharmaceuticals, Inc. Stimulus-inducible i (kappa)b kinase [ikk] signalsome
WO1998035691A1 (en) 1997-02-15 1998-08-20 Proscript, Inc. Treatment of infarcts through inhibition of nf-kappab
US6030834A (en) * 1997-12-30 2000-02-29 Chiron Corporation Human IKK-beta DNA constructs and cells
AU3354499A (en) 1998-03-16 1999-10-11 Cadus Pharmaceutical Corporation Human mekk proteins, corresponding nucleic acid molecules, and uses therefor
US7024312B1 (en) 1999-01-19 2006-04-04 Maxygen, Inc. Methods for making character strings, polynucleotides and polypeptides having desired characteristics
US7062076B1 (en) * 1999-08-27 2006-06-13 Iris Biotechnologies, Inc. Artificial intelligence system for genetic analysis
US7430477B2 (en) 1999-10-12 2008-09-30 Maxygen, Inc. Methods of populating data structures for use in evolutionary simulations
US7018796B2 (en) * 2000-04-07 2006-03-28 Shionogi & Co., Ltd. Preincubation assay methods
US6818427B1 (en) 2000-10-27 2004-11-16 Millennium Pharmaceuticals, Inc. MEKK1 molecules and uses thereof
EP1488335A4 (de) 2002-03-09 2006-11-15 Maxygen Inc Optimierung von crossover-punkten für die gerichtete evolution
US7524664B2 (en) 2003-06-17 2009-04-28 California Institute Of Technology Regio- and enantioselective alkane hydroxylation with modified cytochrome P450
US20070202593A1 (en) * 2006-02-27 2007-08-30 Research Development Foundation Cell-Targeted IKB and Methods for the Use Thereof
US8026085B2 (en) * 2006-08-04 2011-09-27 California Institute Of Technology Methods and systems for selective fluorination of organic molecules
US8252559B2 (en) * 2006-08-04 2012-08-28 The California Institute Of Technology Methods and systems for selective fluorination of organic molecules
WO2008121435A2 (en) * 2007-02-02 2008-10-09 The California Institute Of Technology Methods for generating novel stabilized proteins
US20080268517A1 (en) * 2007-02-08 2008-10-30 The California Institute Of Technology Stable, functional chimeric cytochrome p450 holoenzymes
US8802401B2 (en) * 2007-06-18 2014-08-12 The California Institute Of Technology Methods and compositions for preparation of selectively protected carbohydrates
WO2012135415A1 (en) * 2011-03-29 2012-10-04 Glaxosmithkline Llc Buffer system for protein purification
US9322007B2 (en) 2011-07-22 2016-04-26 The California Institute Of Technology Stable fungal Cel6 enzyme variants
CN107549099A (zh) * 2017-08-30 2018-01-09 佛山市高明区新广农牧有限公司 一种禽白血病的净化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
CA1341288C (en) * 1986-06-27 2001-09-04 Yoshitaka Ono Protein kinase c
US5188964A (en) * 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
AU2140592A (en) 1991-05-17 1992-12-30 Chiron Corporation Inhibitor of nf-kappa b transcriptional activator and uses thereof
US5972674A (en) 1996-08-26 1999-10-26 Signal Pharmaceuticals, Inc. Stimulus-inducible protein kinase complex and methods of use therefor
WO1998008955A1 (en) 1996-08-26 1998-03-05 Signal Pharmaceuticals, Inc. Stimulus-inducible i (kappa)b kinase [ikk] signalsome
US6268194B1 (en) 1997-02-25 2001-07-31 The Regents Of The University Of California IKB kinase and methods of using same
WO1998037228A1 (en) 1997-02-25 1998-08-27 The Regents Of The University Of California IλB KINASE, SUBUNITS THEREOF, AND METHODS OF USING SAME
US6242253B1 (en) 1997-10-09 2001-06-05 Regents Of The University Of California IkB kinase, subunits thereof, and methods of using same

Also Published As

Publication number Publication date
AU2531797A (en) 1997-10-10
KR20000064670A (ko) 2000-11-06
US20020168740A1 (en) 2002-11-14
AU728679B2 (en) 2001-01-18
US6787346B2 (en) 2004-09-07
DE69728880T2 (de) 2005-04-28
EP0910645B1 (de) 2004-04-28
WO1997035014A1 (en) 1997-09-25
JP2000510328A (ja) 2000-08-15
CA2249551A1 (en) 1997-09-25
BR9710408A (pt) 1999-08-17
US7452977B2 (en) 2008-11-18
ES2217407T3 (es) 2004-11-01
AU728679C (en) 2002-03-21
US20020151022A1 (en) 2002-10-17
EP0910645A1 (de) 1999-04-28
US20040161814A1 (en) 2004-08-19
DE69728880D1 (de) 2004-06-03
US6107073A (en) 2000-08-22

Similar Documents

Publication Publication Date Title
ATE265537T1 (de) Kinase für die stellen-spezifische phosphorylierung von i-kappa-b-alpha
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
ES2061273T3 (es) Ensayo para proteinas glicadas de la sangre.
ATE263374T1 (de) Für natives prp-sc spezifische antikörper
ATE248605T1 (de) Für e-selectin und p-selectin spezifische kreuzreaktive monoklonale antikörper
ATE431159T1 (de) Für rsv f-proteine spezifische, menschliche, monoklonale antikörper mit hoher affinität
ATE213639T1 (de) Proteinreinigung
ES2079481T3 (es) Un procedimiento para la determinacion de la actividad funcional de la proteina s o de la proteina c libre en una muestra de plasma.
ATE208493T1 (de) Bioaktive poröse trennteile
DK0948604T3 (da) Screeningsmetoder for forbindelser som binder til PYK2-polypeptidet
DK1068328T3 (da) Behandling og diagnose af stafylokokinfektioner
DE69022860T2 (de) Prüfmodusumschaltsystem für LSI.
GB8901859D0 (en) Diagnostic test
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
SE9300090D0 (sv) Affinitetsrening med komplexbunden ligand
DE69731964D1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
DE69525833D1 (de) Automatische Testeinrichtung für Bremssteuerventil von Schienenfahrzeugen
DK1031035T3 (da) Haptoglobin assay
DE3886545T2 (de) Monoklonale human-antikörper, spezifisch für rh(d).
FI884470A (fi) Biologiskt diagnostiskt analyseringssystem.
DE59002725D1 (de) Betätigungsvorrichtung für Kupplungen von Schienenfahrzeugen.
FR2663748B1 (fr) Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant.
DE29721308U1 (de) Eindampfungsvorrichtung für Proben

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties